• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 C3 与坏死核心体积相关,但也与未来的心血管事件相关。

Apolipoprotein C3 and necrotic core volume are correlated but also associated with future cardiovascular events.

机构信息

Department of Cardiology, Fukushima Red Cross Hospital, Fukushima, Japan.

Department of Cardiology, Takeda General Hospital, Aizuwakamatsu, Japan.

出版信息

Sci Rep. 2022 Aug 25;12(1):14554. doi: 10.1038/s41598-022-18914-1.

DOI:10.1038/s41598-022-18914-1
PMID:36008556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9458721/
Abstract

We aimed to clarify the relationship between apolipoprotein C3 (apo-C3) and the vascular composition of lesion plaque in stable coronary disease (SCD) before percutaneous coronary intervention (PCI), and to investigate major adverse cardiovascular events (MACEs) within 4 years. Data of 98 consecutive patients with SCD who underwent PCI between November 1, 2012, and March 10, 2015, were analyzed. Laboratory and virtual histology-intravascular ultrasound (VH-IVUS) examinations of culprit lesions were conducted before PCI. Patients were divided according to median apo-C3 into low apo-C3 (≤ 8.5 mg/dL) and high apo-C3 (> 8.5 mg/dL) groups. VH-IVUS data indicated that the percentage of necrotic core volume (%NC) was significantly higher in the high apo-C3 group than in the low apo-C3 group. Moreover, the %NC significantly correlated with the apo-C3 level (R = 0.2109, P = 0.037). Kaplan-Meier curve analysis revealed that freedom from MACEs exhibited a greater decrease in the high apo-C3 group than in the low apo-C3 group, and in the high %NC group than in the low %NC group. Multivariate Cox hazards analysis showed that the %NC and high apo-C3 were independent predictors of 4 year MACEs. Apo-C3 may be a useful marker of future MACEs in patients with SCD after PCI and contribute to %NC growth.

摘要

我们旨在明确经皮冠状动脉介入治疗 (PCI) 前稳定型冠状动脉疾病 (SCD) 患者载脂蛋白 C3 (apo-C3) 与病变斑块血管成分之间的关系,并探究 4 年内主要不良心血管事件 (MACEs)。分析了 2012 年 11 月 1 日至 2015 年 3 月 10 日期间行 PCI 的 98 例连续 SCD 患者的数据。在 PCI 前进行了病变的实验室和虚拟组织学血管内超声 (VH-IVUS) 检查。根据 apo-C3 的中位数将患者分为低 apo-C3(≤8.5mg/dL)和高 apo-C3(>8.5mg/dL)组。VH-IVUS 数据表明,高 apo-C3 组的坏死核心体积百分比(%NC)明显高于低 apo-C3 组。此外,%NC 与 apo-C3 水平显著相关(R=0.2109,P=0.037)。Kaplan-Meier 曲线分析显示,高 apo-C3 组的 MACE 无事件率下降幅度大于低 apo-C3 组,高 %NC 组的 MACE 无事件率下降幅度大于低 %NC 组。多变量 Cox 风险分析表明,%NC 和高 apo-C3 是 4 年 MACEs 的独立预测因子。apo-C3 可能是 PCI 后 SCD 患者未来 MACEs 的有用标志物,并有助于 %NC 的增长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/349f/9458721/6a7ef16dcf62/41598_2022_18914_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/349f/9458721/6a7ef16dcf62/41598_2022_18914_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/349f/9458721/6a7ef16dcf62/41598_2022_18914_Fig1_HTML.jpg

相似文献

1
Apolipoprotein C3 and necrotic core volume are correlated but also associated with future cardiovascular events.载脂蛋白 C3 与坏死核心体积相关,但也与未来的心血管事件相关。
Sci Rep. 2022 Aug 25;12(1):14554. doi: 10.1038/s41598-022-18914-1.
2
Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease.载脂蛋白 B 与稳定型冠状动脉疾病斑块内坏死核心体积相关。
PLoS One. 2019 Feb 19;14(2):e0212539. doi: 10.1371/journal.pone.0212539. eCollection 2019.
3
Application of virtual histological intravascular ultrasound in plaque composition assessment of saphenous vein graft diseases.虚拟组织学血管内超声在评估大隐静脉桥病变斑块成分中的应用。
Chin Med J (Engl). 2019 Apr 20;132(8):957-962. doi: 10.1097/CM9.0000000000000183.
4
Impact of culprit plaque volume and composition on myocardial microcirculation following primary angioplasty in patients with ST-segment elevation myocardial infarction: virtual histology intravascular ultrasound analysis.罪犯斑块体积和成分对 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后心肌微循环的影响:虚拟组织学血管内超声分析。
Int J Cardiol. 2013 Aug 10;167(3):1000-5. doi: 10.1016/j.ijcard.2012.03.079. Epub 2012 Apr 4.
5
Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.基于虚拟组织学血管内超声的斑块成分与经皮冠状动脉介入治疗后静脉桥病变患者临床结局的关系:一项前瞻性队列研究的研究方案。
BMC Cardiovasc Disord. 2018 Dec 12;18(1):233. doi: 10.1186/s12872-018-0975-1.
6
[Plaque features in saphenous vein graft evaluated by virtual histology intravascular ultrasound].[应用虚拟组织学血管内超声评估大隐静脉移植血管的斑块特征]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Jan 24;47(1):26-33. doi: 10.3760/cma.j.issn.0253-3758.2019.01.003.
7
Construction and validation of a plaque discrimination score from the anatomical and histological differences in coronary atherosclerosis: the Liverpool IVUS-V-HEART (Intra Vascular UltraSound-Virtual-Histology Evaluation of Atherosclerosis Requiring Treatment) study.从冠状动脉粥样硬化的解剖和组织学差异构建和验证斑块判别评分:利物浦 IVUS-V-HEART(需要治疗的动脉粥样硬化的血管内超声-虚拟组织学评估)研究。
EuroIntervention. 2014 Nov;10(7):815-23. doi: 10.4244/EIJV10I7A141.
8
Plaque structural stress assessed by virtual histology-intravascular ultrasound predicts dynamic changes in phenotype and composition of untreated coronary artery lesions.通过虚拟组织学血管内超声评估的斑块结构应力可预测未经治疗的冠状动脉病变的表型和成分的动态变化。
Atherosclerosis. 2016 Nov;254:85-92. doi: 10.1016/j.atherosclerosis.2016.09.072. Epub 2016 Sep 30.
9
Impact of plaque burden and composition on coronary slow flow in ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: intravascular ultrasound and virtual histology analysis.斑块负荷和成分对接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者冠状动脉慢血流的影响:血管内超声和虚拟组织学分析
Acta Cardiol. 2021 Aug;76(6):650-660. doi: 10.1080/00015385.2020.1767842. Epub 2020 May 26.
10
Circulating Microparticles and Coronary Plaque Components Assessed by Virtual Histology Intravascular Ultrasound of the Target Lesion in Patients with Stable Angina.通过虚拟组织学血管内超声评估稳定型心绞痛患者靶病变的循环微粒与冠状动脉斑块成分
PLoS One. 2016 Jan 26;11(1):e0148128. doi: 10.1371/journal.pone.0148128. eCollection 2016.

引用本文的文献

1
Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease.心血管代谢疾病中极低密度脂蛋白产生的分子调控与治疗靶点
Cell Mol Gastroenterol Hepatol. 2025;19(1):101409. doi: 10.1016/j.jcmgh.2024.101409. Epub 2024 Oct 12.
2
Apolipoprotein C3: form begets function.载脂蛋白C3:形态决定功能。
J Lipid Res. 2024 Jan;65(1):100475. doi: 10.1016/j.jlr.2023.100475. Epub 2023 Nov 14.
3
Hematopoietic NLRP3 and AIM2 Inflammasomes Promote Diabetes-Accelerated Atherosclerosis, but Increased Necrosis Is Independent of Pyroptosis.

本文引用的文献

1
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.降低胆固醇、血压或两者兼用来预防心血管事件:心脏结局预防评估 3 期研究参与者 8.7 年随访结果。
Eur Heart J. 2021 Aug 17;42(31):2995-3007. doi: 10.1093/eurheartj/ehab225.
2
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study.载脂蛋白 CIII 可预测冠心病患者的心血管事件:一项前瞻性观察研究。
Lipids Health Dis. 2020 May 30;19(1):116. doi: 10.1186/s12944-020-01293-9.
3
造血 NLRP3 和 AIM2 炎性小体促进糖尿病加速动脉粥样硬化,但增加的坏死不依赖于细胞焦亡。
Diabetes. 2023 Jul 1;72(7):999-1011. doi: 10.2337/db22-0962.
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII.
载脂蛋白 CIII 升高的心血管病患者缺血性脑血管事件发生率增加。
Stroke. 2020 Jan;51(1):61-68. doi: 10.1161/STROKEAHA.119.026811. Epub 2019 Dec 4.
4
Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease.载脂蛋白 B 与稳定型冠状动脉疾病斑块内坏死核心体积相关。
PLoS One. 2019 Feb 19;14(2):e0212539. doi: 10.1371/journal.pone.0212539. eCollection 2019.
5
Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths.低密度脂蛋白颗粒对聚集的易感性取决于颗粒脂质组,是可调节的,并与未来的心血管死亡相关。
Eur Heart J. 2018 Jul 14;39(27):2562-2573. doi: 10.1093/eurheartj/ehy319.
6
A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.一项关于二十碳五烯酸对接受他汀类药物治疗的冠心病患者疗效的随机对照试验。
J Cardiol. 2017 Dec;70(6):537-544. doi: 10.1016/j.jjcc.2017.07.007. Epub 2017 Aug 31.
7
Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.他汀类药物治疗对斑块成分的影响:一项双盲、随机研究。
J Am Coll Cardiol. 2016 Apr 19;67(15):1772-1783. doi: 10.1016/j.jacc.2016.02.014.
8
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.在无心血管疾病的中危人群中降低胆固醇。
N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2.
9
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.载脂蛋白CIII升高与心血管事件风险:一项系统评价和荟萃分析。
J Clin Lipidol. 2015 Jul-Aug;9(4):498-510. doi: 10.1016/j.jacl.2015.05.002. Epub 2015 May 14.
10
Reproducibility of intravascular ultrasound radiofrequency data analysis (virtual histology) with a 45-MHz rotational imaging catheter in ex vivo human coronary arteries.使用45兆赫旋转成像导管对离体人冠状动脉进行血管内超声射频数据分析(虚拟组织学)的可重复性
J Cardiol. 2015 Feb;65(2):134-42. doi: 10.1016/j.jjcc.2014.05.004. Epub 2014 Sep 18.